Index Entries

G.E. Carpagnano, V. Di Lecce, V. N. Quaranta, A. Zito, E. Buonamico, E. Capozza, A. Palumbo, G. Di Gioia, V. N. Valerio, and O. Resta
August 9, 2020
Journal of Endocrinological Investigation
University of Bari Aldo Moro (Italy)

Results:A survival analysis highlighted that, after 10 days of hospitalization, severe vitamin D deficiency patients had a 50% mortality probability, while those with vitamin D≥10 ng/mL had a 5% mortality risk (p = 0.019)…

Conclusions: High prevalence of hypovitaminosis D was found in COVID-19 patients with acute respiratory failure, treated in a RICU. Patients with severe vitamin D deficiency had a significantly higher mortality risk. Severe vitamin D deficiency may be a marker of poor prognosis in these patients, suggesting that adjunctive treatment might improve disease outcomes.”

document
COVID-19,nutraceuticals,vitamin D